It should be noted that similar but different phenotypes of SBS3 may arise dependent on the underlying cause and even tumor type, e.g., BRCA2 and PALB2 inactivation lead to larger deletions when compared to BRCA1- and RAD51-related HRD [57]. This evidence concerns the gene BRCA2 and neoplasm.